HOME >> BIOLOGY >> NEWS
Budding viral hijackers may co-opt cell machinery for the getaway

When retroviruses like HIV infect cells, they take over the cell's machinery to manufacture new copies of themselves. Research published this week in the top-tier open access journal, Journal of Biology, shows that to escape from cells, retroviruses may once again hijack cellular components, in this case molecules normally used to engulf material from the cell's surroundings in a pocket formed from cell membrane. The findings, offer new insights into how viruses propagate and cause disease, and how healthy cells work.

Retroviruses travel from cell to cell in 'spacecraft' surrounded by the membrane of host cells. These transporters protect the virus from attack by the immune system, as they disguise the virus as part of the body. The outer membrane of the virus particle also helps the virus to spread, as it can fuse with the membrane of other vulnerable cells.

During the construction of a virus particle, or virion, the cell membrane bulges outwards, engulfing viral components as it goes. One of the viral proteins, called Gag, is essential for this process.

Now, researchers from Columbia and Yale Universities, USA, Aijou University, South Korea and the Chinese Academy of Sciences has shown that some retroviral Gag proteins bind tightly to a host-cell protein called endophilin-2. Endophilin-2 is normally involved in the inward budding of the cell membrane, a process known as endocytosis.

Supporting the idea that this interaction is functionally relevant, the researchers found endophilin-2 inside viral particles that had budded from cells infected with Moloney-murine leukaemia virus. On further examination, they also found two other proteins involved in endocytosis, a-adaptin and clathrin, inside the virions. However, Dynamin-2, a protein that binds to endophilin-2, was not there. This suggests that the incorporation of selected proteins is unlikely to be accidental.

Endophilin-2's normal role is to increase the curvature of the
'"/>

Contact: Gemma Bradley
press@biomedcentral.com
44-0-20-7323-0323
BioMed Central
3-Dec-2003


Page: 1 2

Related biology news :

1. Poetically Timed With Spring, Budding Yeast Yield Possible Insight Into Male Fertility--And Infertility
2. First glimpse of DNA binding to viral enzyme
3. X marks the spot: Vector insertion is viral specific
4. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
5. Researchers develop better understanding of immune response to viral infection
6. New papillomavirus target could lead to specific antiviral drugs for precancerous cervical lesions
7. Sick Kids researchers look at viral triggers for multiple sclerosis in children
8. The catch 22 of immune response to AIDs viral infection
9. A viral cure for type 1 diabetes
10. Purdue biologists expose the inner workings of viral machine
11. Retroviral protein triggers proliferation of immune cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: